Spyre Therapeutics Inc. (SYRE)
21.73
0.93 (4.47%)
At close: Jan 15, 2025, 1:52 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -0.44 | -0.45 | -4.75 | -5.19 | -3.12 | -3.52 | -3 | -1.96 | -9.89 | -12.92 | n/a |
| PS Ratio | 167.52 | 16.28 | 16.67 | n/a | n/a | 40.11 | 15.72 | 9.20 | 18.35 | n/a | n/a |
| PB Ratio | 0.81 | 0.75 | 3.72 | 3.00 | 4.06 | 2.31 | 1.63 | 0.68 | 3.09 | 71.40 | n/a |
| P/FCF Ratio | -1.49 | -0.47 | -5.75 | -5.25 | -3.63 | -4.78 | -3.24 | -2.24 | -9.98 | -17.78 | n/a |
| P/OCF Ratio | -1.49 | -0.47 | -5.81 | -5.54 | -3.72 | -4.84 | -3.32 | -2.26 | -10.17 | -18.22 | n/a |
| OCF/S Ratio | -112.77 | -34.41 | -2.87 | n/a | n/a | -8.28 | -4.73 | -4.07 | -1.8 | n/a | n/a |
| Debt / Equity Ratio | 0.46 | 0.09 | 0.06 | 0.04 | 0.09 | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 10.68 | 4.25 | 4.91 | 9.11 | 4.06 | 7.49 | 9.77 | 16.75 | 15.17 | 2.58 | 3.26 |
| Current Ratio | 10.68 | 4.25 | 4.91 | 9.11 | 4.06 | 7.49 | 9.77 | 16.75 | 15.17 | 2.58 | 3.26 |
| Asset Turnover | 0.00 | 0.03 | 0.17 | n/a | n/a | 0.05 | 0.09 | 0.07 | 0.16 | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -1.84 | -1.67 | -0.78 | -0.58 | -1.3 | -0.66 | -0.54 | -0.34 | -0.31 | -5.53 | n/a |
| Return on Assets (ROA) | -0.99 | -1.18 | -0.6 | -0.5 | -0.94 | -0.57 | -0.49 | -0.32 | -0.29 | -3.53 | n/a |
| Return on Capital (ROIC) | -0.78 | -1.5 | -0.73 | -0.56 | -1.24 | -0.67 | -0.55 | -0.35 | -0.31 | -4.76 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -8.8% | 15.67% | 89.32% | n/a | n/a | 100.00% | 100.00% | 100.00% | 98.54% | n/a | n/a |
| Net Profit Margin | -38.24K% | -3.60K% | -351.14% | n/a | n/a | -1.14K% | -523.27% | -468.84% | -185.62% | n/a | n/a |
| Pretax Profit Margin | -38.24K% | -3.60K% | -350.39% | n/a | n/a | -1.14K% | -523.27% | -468.84% | -185.62% | n/a | n/a |
| Operating Profit Margin | -27.35K% | -3.64K% | -350.33% | n/a | n/a | -1.17K% | -531.72% | -473.34% | -185.95% | n/a | n/a |
| FCF Margin | -11.28K% | -3.44K% | -289.71% | n/a | n/a | -838.86% | -484.8% | -411.67% | -183.89% | n/a | n/a |
| EBITDA Margin | -14.43K% | -3.57K% | -339.71% | n/a | n/a | -1.16K% | -526.94% | -470.48% | -184.49% | n/a | n/a |